ask="12.29"
ask_size="300"
average_daily_volume="2095140"
bid="11.75"
bid_size="4000"
book_value="-0.09"
change="-0.13"
change_from_200_day_moving_average="1.12"
change_from_50_day_moving_average="0.64"
change_from_52_week_high="-2.28"
change_From_52_week_low="5.14"
change_in_percent="-1.06%"
close="12.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.90"
ex_dividend_date="N/A"
float_shares="94923000"
high="12.39"
high_52_weeks="14.38"
last_trade_date="2/8/2017"
last_trade_price="12.10"
last_trade_size="78316"
last_trade_time="4:00pm"
low="12.01"
low_52_weeks="6.96"
market_capitalization="1.55B"
moving_average_200_day="10.98"
moving_average_50_day="11.46"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="12.15"
pe_ratio="N/A"
peg_ratio="-0.25"
percent_change_from_200_day_moving_average="+10.16%"
percent_change_from_50_day_moving_average="+5.55%"
percent_change_from_52_week_high="-15.86%"
percent_change_from_52_week_low="+73.85%"
previous_close="12.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.80"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="9.08"
stock_exchange="NMS"
symbol="HALO"
volume="1201102"
weeks_range_52="6.96 - 14.38"
